Clik here to view.
Study: Microneedle patch, protein combo could boost efficacy of flu vaccine
Credit: Georgia State University Researchers at Georgia State University and Georgia Institute of Technology have devised a method to boost the efficacy of a traditional influenza vaccine. The team...
View ArticleClik here to view.
Braeburn, Camurus seek FDA nod for buprenorphine depot
Camurus AB (STO:CAMX) and Braeburn Pharmaceuticals said today that the companies submitted a new drug application to the FDA for its weekly and monthly buprenorphine depots to treat opioid use...
View ArticleClik here to view.
Catalent, Rutgers partner to study pediatric drug formulation and delivery
The Catalent Applied Drug Delivery Institute said today that it inked a deal to work with the dept. of pharmacy practice at Rutgers University in an effort to identify and address the challenges linked...
View ArticleClik here to view.
Kala Pharmaceuticals prices $90m IPO
Kala Pharmaceuticals (NSDQ:KALA) today priced its initial public offering of 6 million shares of common stock at $15.00 apiece. The IPO is slated to bring in nearly $90 million for the Waltham,...
View ArticleClik here to view.
Insulet, Ypsomed go their separate ways
Ypsomed has been the exclusive distributor of Insulet‘s (NSDQ:PODD) Omnipod insulin management system in Europe since 2010. But today, the companies announced that the arrangement is slated to end on...
View ArticleClik here to view.
FTC approves Baxter’s $625m Claris buyout, with conditions
The Federal Trade Commission approved Baxter‘s (NYSE:BAX) $625 million acquisition of Claris Lifesciences‘ (BOM:533288) injectable drug biz, but mandated that the companies divest two drugs products –...
View ArticleClik here to view.
Why Abbott’s CEO is excited about Bigfoot Biomedical and diabetes treatment
Just one week after Abbott (NYSE:ABT) said it inked a deal with Bigfoot Biomedical to develop an automated diabetes management system, CEO Miles White told analysts that he thinks Bigfoot is playing...
View ArticleClik here to view.
Trump pushes ‘America First’ policy with pharmaceutical packaging industry
Donald Trump yesterday revealed an initiative to bring jobs and investment into the U.S. drug packaging industry, spearheaded by Corning Inc. (NYSE:GLW), Merck (NYSE:MRK) and Pfizer (NYSE:PFE). At the...
View ArticleClik here to view.
Endo shutters manufacturing facilities in Huntsville
Endo (NSDQ:ENDP) said today that it plans to close its manufacturing and distribution plants in Huntsville, Alabama, slashing 875 jobs from its workforce. The closing, which is slated to happen over...
View ArticleClik here to view.
Parkinson’s protein to take a trip into space
The Michael J. Fox Foundation for Parkinson’s Research and the Center for the Advancement of Science in Space yesterday inked a collaboration to send a protein linked to Parkinson’s disease to the...
View ArticleClik here to view.
Aerie touts late-stage safety data for Roclatan eye drops
Aerie Pharmaceuticals (NSDQ:AERI) touted 12-month safety data yesterday from the Phase III registration trial of its Roclatan eye drops for intraocular pressure resulting from glaucoma or ocular...
View ArticleClik here to view.
Novocure brings Optune tech to drug trial for glioblastoma
Novocure (NSDQ:NVCR) said today that it joined a Phase Ib study to evaluate the safety of Celgene‘s (NSDQ:CELG) marizomib and temozolomide in combination with Optune for patients with newly-diagnosed...
View ArticleClik here to view.
New GSK chief executive to refocus pipeline
GlaxoSmithKline‘s (NYSE:GSK) new chief executive, Emma Walmsley, signaled in April that she plans to cut programs in the company’s pharmaceutical pipeline that aren’t generating enough value, including...
View ArticleClik here to view.
Healthcare fund Gurnet Point buys Innocoll’s bioresorbable collagen matrix
Healthcare investment fund Gurnet Point said today that it completed its acquisition of pharmaceutical and medical device company Innocoll. According to the deal, Gurnet Point is slated to buy Innocoll...
View ArticleClik here to view.
Study: Antiretroviral drug-eluting ring safe in breastfeeding mothers
An antiretroviral drug released from an experimental vaginal ring to protect women against HIV is absorbed in low concentrations into breastmilk, according to researchers from the NIH-funded...
View ArticleClik here to view.
J&J touts first-in-human data for HIV vaccine
Johnson & Johnson (NYSE:JNJ) touted first-in-human clinical data today for its investigational HIV vaccine in development by its subsidiary, Janssen Pharmaceutical. The Phase I/IIa trial enrolled...
View ArticleClik here to view.
BioLight’s glaucoma insert succeeds in Phase I/IIa trial
BioLight Life Sciences (TLV:BOLT) touted data today from a Phase I/IIa clinical trial evaluating its Eye-D latanoprost insert. The device successfully lowered intraocular pressure during the study’s...
View ArticleClik here to view.
Samumed wins orphan drug status for inhaled IPF therapy
Samumed said today that the FDA awarded orphan drug status to its inhaled idiopathic pulmonary fibrosis therapy, SMo4646. The IPF therapy is administered using a nebulizer and can be used as a...
View ArticleClik here to view.
Pops Diabetes, Children’s Minnesota to test glucometer
Pops Diabetes Care reportedly enrolled the first patient in a clinical trial evaluating its Pops! one glucometer, according to the StarTribune. The Twin Cities-based company is said to be partnering...
View ArticleClik here to view.
Provention Bio wants to stop Type I diabetes – with a vaccine
Before he co-founded Provention Bio, Ashleigh Palmer worked on inhaled nitric oxide for infants with respiratory failure. After the company was sold for $1.2 billion to a Baxter-led consortium, Palmer...
View Article